Shiga Toxin–Producing <i>Escherichia coli</i> Transmission via Fecal Microbiota Transplant
Caroline Zellmer, Mohamad Sater, Miriam Huntley, Majdi Osman, Scott W. Olesen, Bharat Ramakrishna
Abstract
Fecal microbiota transplantation (FMT) is recommended therapy for multiply recurrent Clostridioides difficile infection. We report adverse events in 7 patients who received FMT from a stool donor who was colonized with Shiga toxin-producing Escherichia coli (STEC). No patients died of FMT-transmitted STEC. Improved screening can likely avoid future transmission.
Topics & Concepts
Fecal bacteriotherapyMedicineFecesEscherichia coliMicrobiologyShiga toxinTransmission (telecommunications)ClostridioidesShiga-like toxinClostridium difficileAdverse effectInternal medicineBiologyAntibioticsBiochemistryGeneEngineeringElectrical engineeringClostridium difficile and Clostridium perfringens researchMicroscopic ColitisHelicobacter pylori-related gastroenterology studies